EUVIMEDEUVIMED entdecken
VergleichsstudieÄquivalenzstudieMultizentrische StudieOpen Access · CC BY-NC-ND 4.0

Comparison of 2 Paclitaxel-Coated Balloons with Different Excipients for the Treatment of Femoropopliteal Artery Disease: A Randomized Prospective Trial

Tae Won Choi, Je Hwan Won, Jinoo Kim, Jin Hyun Joh, Jewon Jeong, Sang Woo Park, Jung Suk Oh, Hyoung Ook Kim, Chang Won Kim, Hwan Jun Jae

Journal of Vascular and Interventional Radiology · 2025

DOI: 10.1016/j.jvir.2025.01.033 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Vascular and Interventional Radiology, 2025. Verfasst von Tae Won Choi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Ajou University Hospital, Ajou University School of Medicine, Suwon, Republic of Korea. Hauptthemen laut MEDLINE: Angioplasty, Balloon, Cardiovascular Agents, Coated Materials, Biocompatible, Excipients. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To evaluate the effectiveness and safety of a novel drug-coated balloon (DCB), Genoss DCB (Genoss), using shellac plus vitamin E as an excipient, compared with a reference DCB using urea. MATERIALS AND METHODS: Patients with femoropopliteal arterial disease under Rutherford Classes 2-5 were enrolled in this prospective, multicenter, noninferiority clinical trial and randomly assigned 1:1 to Genoss DCB and IN.PACT Admiral (Medtronic, Dublin, Ireland). The primary endpoint was late lumen loss at 6 months, which was evaluated using computed tomography (CT) angiography by an independent investigator blinded to the treatment assignment. RESULTS: A total of 119 patients from 10 institutions in the Republic of Korea were assigned to the Genoss DCB (n = 59) and IN.PACT Admiral (n = 60) groups. The late lumen losses were -0.08 mm (SD ± 0.59) in the Genoss DCB group and 0.02 mm (SD ± 0.72) in the IN.PACT Admiral group (P = .469). The upper limit of the 1-sided 97.5% confidence interval for differences in late lumen loss was 0.17 mm, lower than the noninferiority limit of 0.50 mm, demonstrating the noninferiority of Genoss DCB compared with IN.PACT Admiral. In addition, the 2 groups showed no significant differences in clinically-driven target lesion revascularization, major amputation, and all-cause mortality. CONCLUSIONS: The safety and 6-month late lumen loss of a new DCB using shellac plus vitamin E as excipients were noninferior compared with those of the reference DCB using urea as the excipient.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angioplasty, BalloonCardiovascular AgentsCoated Materials, BiocompatibleExcipientsFemoral ArteryPaclitaxelPeripheral Arterial DiseasePopliteal ArteryUreaVascular Access DevicesVitamin EAgedFemaleHumansMaleMiddle AgedEquipment DesignProspective StudiesRepublic of KoreaTime FactorsTreatment OutcomeVascular Patency

Substanzen

Cardiovascular AgentsCoated Materials, BiocompatibleExcipientsPaclitaxelUreaVitamin E

Autor:innen und Institutionen

  • Department of Radiology, Ajou University Hospital, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Department of Radiology, Ajou University Hospital, Ajou University School of Medicine, Suwon, Republic of Korea. Electronic address: wonkwak@ajou.ac.kr.
  • Department of Vascular Surgery, Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine, Seoul, Republic of Korea.
  • Department of Radiology, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Republic of Korea.
  • Department of Radiology, Konkuk University Hospital, Konkuk University School of Medicine, Seoul, Republic of Korea.
  • Department of Radiology, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Republic of Korea.

Zitieren

APA

Choi, T. W., Won, J. H., Kim, J., Joh, J. H., Jeong, J., Park, S. W., Oh, J. S., Kim, H. O., Kim, C. W., & Jae, H. J. (2025). Comparison of 2 Paclitaxel-Coated Balloons with Different Excipients for the Treatment of Femoropopliteal Artery Disease: A Randomized Prospective Trial. Journal of Vascular and Interventional Radiology. https://doi.org/10.1016/j.jvir.2025.01.033

Vancouver

Choi TW, Won JH, Kim J, Joh JH, Jeong J, Park SW, et al. Comparison of 2 Paclitaxel-Coated Balloons with Different Excipients for the Treatment of Femoropopliteal Artery Disease: A Randomized Prospective Trial. Journal of Vascular and Interventional Radiology. 2025. doi:10.1016/j.jvir.2025.01.033

BibTeX
@article{Choi2025,
  author = {Choi, Tae Won and Won, Je Hwan and Kim, Jinoo and Joh, Jin Hyun and Jeong, Jewon and Park, Sang Woo and Oh, Jung Suk and Kim, Hyoung Ook and Kim, Chang Won and Jae, Hwan Jun},
  title = {Comparison of 2 Paclitaxel-Coated Balloons with Different Excipients for the Treatment of Femoropopliteal Artery Disease: A Randomized Prospective Trial},
  journal = {Journal of Vascular and Interventional Radiology},
  year = {2025},
  doi = {10.1016/j.jvir.2025.01.033}
}
Kostenlos starten →